Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis

American Journal of Gastroenterology

Volumn 108, Issue 1, 2013, Pages 75-82

  Berzigotti, Annalisa ^a,b,c   Erice, Eva ^a   Gilabert, Rosa ^b,c   Reverter, Enric ^a,c   Abraldes, Juan G ^a,c   García Pagan, Juan Carlos ^a,c   Bosch, Jaime ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; RENIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; BILIRUBIN BLOOD LEVEL; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHILD PUGH SCORE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FRAMINGHAM RISK SCORE; HEMODYNAMICS; HEPATITIS; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NON INVASIVE PROCEDURE; OBESITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERUM; SODIUM BLOOD LEVEL; SYSTEMIC ENDOTHELIAL DYSFUNCTION; THROMBOCYTE COUNT; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; AGED; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPAIN; VASODILATION; YOUNG ADULT;

EID: 84872027204     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.362     Document Type: Article

References (37)

1. Bosch J, Abraldes JG, Fernandez M et al. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 2010; 53: 558-67.
2. Wiest R, Groszmann RJ. Th e paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002; 35: 478-91.
3. Kharbanda RK, Deanfield JE. Functions of the healthy endothelium. Coron Artery Dis 2001; 12: 485-91.
4. Albillos A, Rossi I, Cacho G et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995; 268: G459-64.
5. Claria J, Jimenez W, Ros J et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994; 20: 1615-21.
6. Gadano AC, Sogni P, Yang S et al. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J Hepatol 1997; 26: 678-86.
7. Weigert AL, Martin PY, Niederberger M et al. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995; 22: 1856-62.
8. Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007; 46: 927-34.
9. Howell WL, Manion WC. Th e low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17, 731 autopsies. Am Heart J 1960; 60: 341-4.
10. Marchesini G, Ronchi M, Forlani G et al. Cardiovascular disease in cirrhosis-a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 1999; 94: 655-62.
11. Vanecek R. Atherosclerosis and cirrhosis of the liver. Bull World Health Organ 1976; 53: 567-70.
12. Blei AT, Mazhar S, Davidson CJ et al. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol 2007; 41 (Suppl 3): S323-9.
13. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003; 145: 943-51.
14. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
15. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
16. Heitzer T, Schlinzig T, Krohn K et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-8.
17. Cazzaniga M, Salerno F, Visentin S et al. Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index. Liver Int 2008; 28: 1396-401.
18. INE base Instituto Nacional de Estadística (INE). Instituto Nacional de Estad ística (INE), Espa ñ a 2010. Available from http://www. ine. es/inebmenu/indice. htm.
19. Grau M, Elosua R, Cabrera de LA et al. Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study. Rev Esp Cardiol 2011; 64: 295-304.
20. Wilson PW, D ' Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
21. Th ird Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
22. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012; 220: 128-33.
23. Junyent M, Gilabert R, Nunez I et al. Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort. Med Clin (Barc) 2005; 125: 770-4.
24. Th ijssen DH, Black MA, Pyke KE et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011; 300: H2-12.
25. NeunteuflT, Heher S, Katzenschlager R et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-10.
26. Bosch J, Garcia-Pagan JC, Berzigotti A et al. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006; 26: 348-62.
27. Berzigotti A, Bonfiglioli A, Muscari A et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int 2005; 25: 331-6.
28. Kane WC, Aronson SM. Cerebrovascular disease in an autopsy population. . 4. Reduced frequency of stroke in patients with liver cirrhosis. Trans Am Neurol Assoc 1971; 96: 259-60.
29. Melato M, Mucli E, Poldrugo F et al. Stroke-cirrhosis relationship: an autopsy study in a heavy drinking population. Ital J Gastroenterol 1991; 23: 211-4.
30. Raval Z, Harinstein ME, Skaro AI et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58: 223-31.
31. Johnston SD, Morris JK, Cramb R et al. Cardiovascular morbidity and mortality aft er orthotopic liver transplantation. Transplantation 2002; 73: 901-6.
32. Dec GW, Kondo N, Farrell ML et al. Cardiovascular complications following liver transplantation. Clin Transplant 1995; 9: 463-71.
33. Keeffe BG, Valantine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001; 7: 755-61.
34. Cournot M, Bura A, Cambou JP et al. arterial ultrasound screening as a tool for coronary risk assessment in asymptomatic men and women. Angiology 2012; 63: 282-8.
35. Angeloni L, Berzigotti A, Bianchi G et al. Systemic endothelial function evaluated by flow-mediated dilatation of brachial artery in patients with liver cirrhosis. J Hepatol 2005; 42 (Suppl 2): 64.
36. Petta S, Torres D, Fazio G et al. Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology 2012; 55: 1317-23.
37. Bellot P, Garcia-Pagan JC, Frances R et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 2010; 52: 2044-52.